Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingUse of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyPharmacokinetic and tissue distribution of paclitaxel in rabbits assayed by LC-UV after intravenous administration of its novel liposomal formulation.The redox basis of epigenetic modifications: from mechanisms to functional consequences.Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.Metabolic engineering for the production of clinically important molecules: Omega-3 fatty acids, artemisinin, and taxol.Microfluidic-assisted self-assembly of complex dendritic polyethylene drug delivery nanocapsules.Palmitoyl ascorbate liposomes and free ascorbic acid: comparison of anticancer therapeutic effects upon parenteral administration.In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel.Microfluidic assisted self-assembly of chitosan based nanoparticles as drug delivery agents.Recent progress in multidrug delivery to cancer cells by liposomes.
P2860
Q26778234-1F081433-402B-40BF-9D13-C4A046F20B08Q30456053-899E45FA-E49B-4488-BA2D-144D4576F772Q33859472-FF175658-9EF8-4B60-9529-52FD959BE9BCQ34871917-B89A83CF-2470-4D0D-AFB6-C434B317C1E4Q35055739-0A77D45C-D678-469A-9EB6-EFAE3C960016Q37134733-F9404B4C-AE59-4261-AE6C-C7F8B1C162E3Q37488026-33587390-11E0-4836-A0B3-98D2F57DE9EDQ37948715-D796B4E4-D178-41A8-8E97-0DFE1BD27FEEQ39017196-C70C4929-15C3-40DA-ADD3-5A2DAB0EEB95Q39489645-6B2C9E2F-AD17-40FA-BD00-68D2DB09335DQ39644963-340744D4-4FAF-4288-B743-F0919EBA2B0FQ43742571-E3356A0F-E0CD-416B-90DF-5A86B8714DB0Q44874958-57B7259F-32B3-402B-BE8D-9EDC08ECDA54
P2860
Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@en
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@nl
type
label
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@en
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@nl
prefLabel
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@en
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@nl
P2093
P1476
Palmitoyl ascorbate-modified l ...... ty and paclitaxel co-delivery.
@en
P2093
Karen Rockwell
Onkar S Vaze
Rupa R Sawant
Vladimir P Torchilin
P304
P356
10.1016/J.EJPB.2010.04.010
P407
P577
2010-04-28T00:00:00Z